Back to SYRE
Paradigm Biocapital Advisors LP → SYRE
Paradigm Biocapital Advisors LP SYRE Position History
Spyre Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$396.8M
Q3 2026
Peak value
$396.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $48.1M |
| Q1 2026 | $98.7M |
| Q2 2026 | $341M |
| Q3 2026 | $396.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $396.8M | 4.46M | — | — |
| Q2 2026 | $341M | 3.84M | — | — |
| Q1 2026 | $98.7M | 1.96M | — | — |
| Q4 2025 | $48.1M | 1.47M | — | — |
Other funds holding SYRE
$809.9M
$795.4M
$430.1M
$383.5M
$377.5M
$348.1M
$336.7M